HOME         WEBSITE         SUBSCRIBE           E-GREETINGS   
                               

Monday, April 27, 2009

News Flash

Asian Airline, Hog-Related Stocks Decline on Swine Flu; Drugmakers Advance Airlines and meat-processing companies slumped in Asia on concern the growing number of swine-flu cases in the U.S. and Mexico will slow a recovery in the global economy and hurt earnings. Medical shares gained.

Cipla Can Supply 1.5 Million Doses of Generic Tamiflu to Fight Swine Flu Cipla Ltd., India’s second-biggest drugmaker by market value, said it can supply 1.5 million doses of generic Tamiflu drugs to help fight an outbreak of swine flu.

Sensitive Index Advances for a Third Day; ICICI Climbs on Goldman Upgrade India’s Sensitive index rose for a third day. ICICI Bank Ltd., the nation’s second-largest by assets, advanced after its rating was raised at Goldman, Sachs & Co. on improving earnings.

Rupee Weakens on Speculation India's Importers Are Purchasing More Dollars India’s rupee dropped for the first time in four days on speculation some importers increased dollar purchases to settle month-end bills.

Sell Indian Stocks Ahead of National Election Results, Credit Suisse Says Investors should lower their holdings of Indian stocks on concern the nation’s ongoing elections may prove a “sharp disappointment,” Credit Suisse Group said.

Reliance Resumes Oil Production at Offshore Field After Monthlong Shutdown Reliance Industries Ltd., India’s most valuable company, resumed oil production at a field off the nation’s east coast after a monthlong shutdown, according to the country’s oil regulator.

Ten-Year Bonds Drop Most in a Month as Eight-Week Low Yields Deter Buyers India’s 10-year bonds fell the most in a month, reversing earlier gains, as yields at the lowest level in eight weeks prompted investors to sell the securities.

Stocks, Grains, Peso Decline as Swine Flu Spreads; Treasuries, Yen Advance U.S. stocks declined, extending a global drop, while the yen, dollar and Treasuries gained as the swine flu outbreak spread. Mexico’s peso fell the most in four months and grain prices retreated.

GM Offers to Exchange $27 Billion of Debt for Equity to Avert Bankruptcy General Motors Corp. asked its bondholders to exchange $27 billion of claims for equity to help the biggest U.S. automaker avert bankruptcy.

Chrysler Reaches Labor Agreement With U.S. Union, Ratification in Canada Chrysler LLC, racing against an April 30 deadline to cut labor costs or face bankruptcy, reached a tentative contract agreement with its biggest U.S. union and won ratification of an accord with Canadian workers.

Goldman Sachs Increases Risk-Taking at Fastest Pace in Wall Street Trading Goldman Sachs Group Inc., unbowed by the securities industry’s worst year since the Great Depression, increased its trading bets at the fastest rate on Wall Street.

Bernanke Credit Warming Prompts Record Company Debt With Libor-OIS Retreat Wherever you look, Federal Reserve Chairman Ben S. Bernanke’s efforts to repair global credit markets are showing signs of working.

Stress Tests May Compel U.S. Banks to Convert TARP Stock to Common Shares U.S. banks that received results of their federal stress tests last week were given three options if they need additional capital to withstand the recession. The reality is they may only have one.

Mexico's Stocks Cut to `Underweight' from `Top Pick' by UBS on Swine Flu Mexican stocks were downgraded by UBS AG to “underweight” from “top pick” among Latin American equities on concern the country’s economic outlook may worsen because of the outbreak of a deadly swine flu.

source: Bloomberg

Blog Archive

____________________________________________________________________________________________

Disclaimer - All investments in Mutual Funds and securities are subject to market risks and uncertainty of dividend distributions and the NAV of schemes may go up or down depending upon factors and forces affecting securities markets generally. The past performance of the schemes is not necessarily indicative of the future performance and may not necessarily provide a basis for comparison with other investments. Investors are advised to go through the respective offer documents before making any investment decisions. Prospective client(s) are advised to go through all comparable products in offer before taking any investment decisions. Mutual Funds and securities investments are subject to market risks and there is no assurance or guarantee that the objectives of the fund will be achieved. Information gathered & material used in this document is believed to be from reliable sources. Decisions based on the information provided on this newsletter/document are for your own account and risk.


In the preparation of the material contained in this document, Varun Vaid has used information that is publicly available, including information developed in-house. Some of the material used in the document may have been obtained from members/persons other than the Varun Vaid and which may have been made available to Varun Vaid. Information gathered & material used in this document is believed to be from reliable sources. Varun Vaid however does not warrant the accuracy, reasonableness and/or completeness of any information. For data reference to any third party in this material no such party will assume any liability for the same. Varun Vaid does not in any way through this material solicit any offer for purchase, sale or any financial transaction/commodities/products of any financial instrument dealt in this material. All recipients of this material should before dealing and or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice.


Varun Vaid, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of this material in any manner. The recipient alone shall be fully responsible/are liable for any decision taken on the basis of this material. All recipients of this material should before dealing and/or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice. The investments discussed in this material may not be suitable for all investors. Any person subscribing to or investigating in any product/financial instruments should do soon the basis of and after verifying the terms attached to such product/financial instrument. Financial products and instruments are subject to market risks and yields may fluctuate depending on various factors affecting capital/debt markets. Please note that past performance of the financial products and instruments does not necessarily indicate the future prospects and performance there of. Such past performance may or may not be sustained in future. Varun Vaid, including persons involved in the preparation or issuance of this material may; (a) from time to time, have long or short positions in, and buy or sell the securities mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation in the financial instruments/products/commodities discussed here in or act as advisor or lender / borrower in respect of such securities/financial instruments/products/commodities or have other potential conflict of interest with respect to any recommendation and related information and opinions. The said person may have acted upon and/or in a manner contradictory with the information contained here. No part of this material may be duplicated in whole or in part in any form and or redistributed without the prior written consent of Varun Vaid. This material is strictly confidential to the recipient and should not be reproduced or disseminated to anyone else.


Varun Vaid also does not take any responsibility for the contents of the advertisements published. Readers are advised to verify the contents on their own before acting there upon.


Published Credits goes to following sources & all the mentioned sources as footer below the published material- Bloomberg, Valueresearch Online, Capital Market, Navindia, Franklin Templeton, Kitco, SBI AMC, LIC AMC, JM Financial AMC, HDFC AMC, The Hindu, Business Line, Personal FN, Economic Times, Reuters, Outlook Money, Business Standard, Times of India etc.